All News

How Long-Acting Injectable PrEP Reshapes the Patient–Provider Relationship
December 18, 2025

Primary care physician Kevin Hatfield, MD, discusses how the switch can increase patient touchpoints, free cognitive burden, and strengthen long-term engagement between patients and PCPs.

In CRC Screening, Progress Looks More Like Improved Follow-Through vs Next Breakthrough: Discussion with Mark Fendrick, MD
December 18, 2025

Moving patients from considering screening to completing it remains the central challenge in colorectal cancer prevention, Fendrick explained to Patient Care.

Zasocitinib Demonstrates Superiority vs Placebo and Apremilast in Phase 3 Plaque Psoriasis Trials
December 18, 2025

Zasocitinib showed significant efficacy in treating moderate-to-severe plaque psoriasis, outperforming placebo and apremilast in pivotal phase 3 trials.

Novo Nordisk Files NDA for CagriSema, Novel GLP-1-amylin Combination for Chronic Weight Management
December 18, 2025

The phase 3 REDFINE program showed mean weight loss of 20% at 68 weeks, supporting the dual-mechanism approach that combines semaglutide with cagrilintide.

Hidradenitis Suppurativa: A Comprehensive Care Plan for Primary Care
December 18, 2025

This is a summary of the multisystem effects of hidradenitis suppurativa followed by practical tips for primary care in recognizing and managing the chronic skin condition.

Tezepelumab Achieves Dual Benefit in Adults with Severe Asthma: Daily Dose
December 17, 2025

Your daily dose of the clinical news you may have missed.

GLP-1 RAs Carry Higher Risk of Serious GI Side Effects Than SGLT-2 Inhibitors: Daily Dose
December 17, 2025

Your daily dose of the clinical news you may have missed.

Epicutaneous Immunotherapy Patch Reduces Peanut Reactivity in Children, Phase 3 Data Show
December 17, 2025

The VITESSE trial met its primary endpoint, with the VIASKIN Peanut patch improving desensitization versus placebo in peanut-allergic children aged 4 to 7 years.

Colorectal Cancer Screening in 2025: What Changed, and What Didn't, with Mark Fendrick, MD
December 17, 2025

Physician researcher Fendrick offers an expert perspective on why removing cost barriers matters, and why navigation and patient realities still determine whether CRC screening succeeds.